Skip to main content
Springer Nature Link
Log in
Menu
Find a journal Publish with us Track your research
Search
Cart
  1. Home
  2. Diabetologia
  3. Article

Brittle diabetes — present concepts

  • Published: 01 August 1985
  • Volume 28, pages 579–589, (1985)
  • Cite this article
Download PDF
Diabetologia Aims and scope Submit manuscript
Brittle diabetes — present concepts
Download PDF
  • G. V. Gill1,
  • S. Walford1 &
  • K. G. M. M. Alberti1 

  • 596 Accesses

  • 43 Citations

  • Explore all metrics

Article PDF

Download to read the full article text

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

References

  1. Woodyatt RT (1938) Diabetes mellitus. In: Cecil R (ed) A Textbook of Medicine, 4th edn, WB Saunders, Philadelphia, p 620

    Google Scholar 

  2. Rosenbloom A (1971) The management of brittle diabetes in children. South Med J 64: 729–733

    Article  CAS  PubMed  Google Scholar 

  3. Colwell AR (1970) Clinical use of insulin. In: Ellenberg M, Rifkin H (eds) Diabetes mellitus: theory and practice. McGraw-Hill, New York, pp 624–637

    Google Scholar 

  4. Tattersall R (1977) Brittle diabetes. Clin Endocrinol Metab 6: 403–419

    Article  CAS  PubMed  Google Scholar 

  5. Knowles HC (1964) In: Diabetes mellitus: diagnosis and treatment. Am Diabetes Assoc, New York, pp 109–111

    Google Scholar 

  6. Marble A (1971) Insulin in the treatment of diabetes. In: Marble A, White P, Bradley RF, Krall LP (eds) Joslin's diabetes mellitus. Lea & Febiger, Philadelphia, pp 287–301

    Google Scholar 

  7. Plauchu M, Pousset G, de Montgolfier R, Hierle P (1970) Etude cliniques et therapeutique due diabete instable de l'adulte. J Med Lyon 1187: 1167–1197

    Google Scholar 

  8. Kissel P, Debry G, Collesson L (1961) Les diabetes instables. Rev Fr Endocrinol Clin Nutr Metab 2: 451–466

    CAS  Google Scholar 

  9. Chimenies H, Laurent C (1965) Diagnostic et traitement des diabetes instables. Diabete 13: 115–125

    Google Scholar 

  10. Lufkin EG (1978) Management of unstable diabetes. Minn Med 59: 753–756

    Google Scholar 

  11. Gill GV, Husband DJ, Walford S, Marshal SM, Home PD, Alberti KGMM (1985) Clinical features of brittle diabetes, in: Pickup JC (ed) Brittle diabetes. Blackwell, Oxford, pp 29–40

    Google Scholar 

  12. Lev-Ran A (1978) Clinical observations on brittle diabetes. Arch Intern Med 138: 372–376

    Article  CAS  PubMed  Google Scholar 

  13. Somogyi M (1959) Exacerbation of diabetes by excess insulin action. Am J Med 26: 169–191

    Article  CAS  PubMed  Google Scholar 

  14. Gale EAM, Tattersall RB (1979) Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet 1: 1049–1052

    Article  CAS  PubMed  Google Scholar 

  15. Gale EAM, Kurtz AB, Tattersall RB (1980) In search of the Somogyi effect. Lancet 2: 279–282

    Article  CAS  PubMed  Google Scholar 

  16. Francis AJ, Home PD, Hanning I, Alberti KGMM, Tunbridge WMG (1983) Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast. Br Med J 186: 1173–1176

    Article  Google Scholar 

  17. Leading Article (1984) Dawn phenomenon in diabetes. Lancet 1: 1333–1334

    Google Scholar 

  18. Bolli GB, Gottesman IS, Campbell PJ, Haymond MW, Cryer PE, Gerich JE (1984) Glucose counterregulation and waning of insulin in the Somogyi Phenomenon (posthypoglycaemic hyperglycaemia). New Engl J Med 311: 1214–1219

    Article  CAS  PubMed  Google Scholar 

  19. Gale EAM, Tattersall RB (1979) Brittle diabetes. Br J Hosp Med 21: 589–597

    Google Scholar 

  20. Bloom ME, Mintz DH, Field JB (1969) Insulin-induced posthypoglycaemic hyperglycaemia as a cause of “brittle” diabetes. Am J Med 47: 891–903

    Article  CAS  PubMed  Google Scholar 

  21. Constam GR (1962) Erfahrungen bei Behandlung labiler Zukkerkranker. Dtsch Med Wochenschr 87: 2184–2188

    Article  CAS  PubMed  Google Scholar 

  22. Petrides P (1966) Der labile Diabetes. Pathophysiologie, Klinik, Therapie. Dtsch Med Wochenschr 91: 689–694

    Article  CAS  PubMed  Google Scholar 

  23. Luft R, Olivecrona H, Sjögren B (1955) Hypophysectomy in man: experience in severe diabetes mellitus. J Clin Endocrinol 15: 391–408

    Article  CAS  Google Scholar 

  24. Bollinger RE (1971) Brittle diabetes. J Kans Med Soc 72: 128–132

    Google Scholar 

  25. Linde J, Nilsson LH, Barany FR (1977) Diabetes and hypoglycaemia in chronic pancreatitis. Scand J Gastroenterol 12: 369–373

    Article  CAS  PubMed  Google Scholar 

  26. Pickup JC, Williams G, Johns P, Keen H (1983) Clinical features of brittle diabetic patients unresponsive to optimized subcutaneous insulin therapy. Diabetes Care 6: 279–284

    Article  CAS  PubMed  Google Scholar 

  27. Bradley C (1982) Psychophysiological aspects of the management of diabetes mellitus. Intern J Mental Health 11: 117–132

    Article  Google Scholar 

  28. Bradley C (1985) Psychological aspects of diabetes. In: Alberti KGMM, Krall LP (eds) Diabetes annual. Elsevier, Amsterdam, pp 374–388

    Google Scholar 

  29. Grant I, Kyle GC, Teichman A (1974) Recent life events and diabetes in adults. Psychosom Med 36: 121–128

    Article  CAS  Google Scholar 

  30. Fisher EB, Delamater AM, Bertelson AD, Kirkely BG (1982) Psychological factors in diabetes and its treatment. J Consult Clin Psychol 50: 993–1003

    Article  PubMed  Google Scholar 

  31. Watts FN (1980) Behavioural aspects of the management of diabetes mellitus: education, self-care and metabolic control. Behav Res Ther 18: 171–180

    Article  CAS  PubMed  Google Scholar 

  32. Baker L, Kay R, Hague N (1969) Metabolic homeostasis in juvenile diabetes mellitus. Increased ketone responsiveness to epinephrine. Diabetes 18: 421–427

    Article  CAS  PubMed  Google Scholar 

  33. Hinkle LE, Wolf S (1952) Importance of life stress in course and management of diabetes mellitus. J Am Med Assoc 148: 513–520

    Article  PubMed  Google Scholar 

  34. Baker L, Barcai A, Kaye R, Hague N (1969) Beta adrenergic blockade and juvenile diabetes: acute studies and long-term therapeutic trial. J Pediatr 75: 19–29

    Article  CAS  PubMed  Google Scholar 

  35. Tattersall R, Walford S (1984) Brittle diabetes, a spectrum of illness in response to life stress: the place of “cheating and manipulation”. In: Pickup JC (ed) Brittle diabetes. Blackwell, Oxford, pp 76–102

    Google Scholar 

  36. Loughlin WC, Mosenthal HO (1944) Study of the personalities of children with diabetes. Am J Dis Child 68: 13–15

    Google Scholar 

  37. Rosen H, Lidz T (1949) Emotional factors in the precipitation of recurrent diabetic acidosis. Psychosom Med 11: 211–215

    Article  CAS  PubMed  Google Scholar 

  38. Gill GV, Walford S, Alberti KGMM (1984) Brittle diabetes — all in the mind? Diabetologia 27: 279 A

  39. Martin WP, Martin HE, Lyster RW, Strouse S (1941) Insulin resistance. J Clin Endocrinol 1: 387–398

    Article  CAS  Google Scholar 

  40. Flier JS, Kahn CR, Roth J, Bar R (1975) Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with insulin resistance. Science 190: 63–65

    Article  CAS  PubMed  Google Scholar 

  41. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J (1976) The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. New Engl J Med 294: 739–745

    Article  CAS  PubMed  Google Scholar 

  42. Grunberger G, Taylor SI, Dons RF, Gorden P (1983) Insulin receptors in normal and disease states. Clin Endocrinol Metabol 12: 191–219

    Article  CAS  Google Scholar 

  43. Rennie A, Hamilton RG, Adkinson NF, Rendell MS (1981) Hyperlabile diabetes accompanied by insulin resistance. Clin Chem 27: 1463–1464

    Google Scholar 

  44. Christy M, Deckert T, Nerup J (1977) Immunity and autoimmunity in diabetes mellitus. Clin Endocrinol Metabol 6: 305–332

    Article  CAS  Google Scholar 

  45. Kahn CR, Rosenthal AS (1979) Immunologic reactions to insulininsulin allergy, insulin resistance and the autoimmune insulin resistance syndrome. Diabetes Care 2: 283–295

    Article  CAS  PubMed  Google Scholar 

  46. Dandona P, Foster M, Healey F, Greenbury E, Beckett AG (1978) Low dose insulin infusions in diabetic patients with high insulin requirements. Lancet 2: 283–285

    Article  CAS  PubMed  Google Scholar 

  47. Williams G, Pickup J, Clark A, Bowcock S, Cook E, Keen H (1983) Changes in blood flow close to subcutaneous insulin injection sites in brittle diabetics. Diabetes 32: 466–473

    Article  CAS  PubMed  Google Scholar 

  48. Friedenberg GR, White N, Cateland S, O'Dorisio TM, Sotos JF, Santiago JV (1981) Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin. New Engl J Med 305: 363–368

    Article  Google Scholar 

  49. Leading article (1980) Subcutaneous injections and absorption of insulin. Lancet 1: 1005–1006

    Google Scholar 

  50. Gill GV, Home PD, Massi-Benedetti M, Pernet A, Capaldo B, Husband DJ, Barrin JM, Johnston DG, Alberti KGMM (1981) Clinical and metabolic characteristics of patients with “brittle” diabetes. Diabetologia 21: 507

    Google Scholar 

  51. Schade DS, Duckworth WC, Drumm DA, Eaton RP (1984) In search of the subcutaneous insulin degradation syndrome. Diabetologia 27: 327A

  52. Shima K, Tanaka R, Morishita S, Tarui S, Kumahara Y, Nishikawa M (1977) Studies on the etiology of “brittle diabetes”. Relationship between diabetic instability and insulinogenic reserve. Diabetes 26: 717–725

    Article  CAS  PubMed  Google Scholar 

  53. Dorner M, Pinget M, Brogard JM (1977) Des essentielle instable Diabetes. Muench Med Wochenschr 119: 671–674

    CAS  Google Scholar 

  54. Dixon K, Exon PD, Hughes HR (1972) Insulin antibodies in aetiology of labile diabetes. Lancet 1: 343–347

    Article  CAS  PubMed  Google Scholar 

  55. Bruck E, MacGillivram MH (1975) Interaction of endogenous growth hormone, Cortisol and catecholamines with blood glucose in children with brittle diabetes mellitus. Paediatr Res 9: 535–541

    Article  CAS  Google Scholar 

  56. Drejer J, Hendriksen C, Nielsen LM, Binder C, Hagen C, Kehlet H (1977) Diurnal variations in plasma prolactin, growth hormone, cortisol and blood glucose in labile diabetes mellitus. Clin Endocrinol 6: 57–74

    Article  CAS  Google Scholar 

  57. Oleesky S, Shreeve DR, Sutcliffe CH (1974) Brittle diabetes. Quart J Med 43: 113–125

    CAS  PubMed  Google Scholar 

  58. Massi-Benedetti M, Noy GA, Nosadini R, Nattrass M, Gill GV, Orskov H (1980) Metabolic abnormalities in “brittle” diabetes. Diabetologial 19: 297

    Google Scholar 

  59. Molnar GD, Taylor WF, Longworthy AL, Fatourechi V (1972) Diurnal growth hormone and glucose abnormalities in unstable diabetics: studies of ambulatory-fed subjects during continuous blood glucose analysis. J Clin Endocrinol 34: 837–846

    Article  CAS  Google Scholar 

  60. Renolds C, Molnar GD, Horwitz DL, Rubenstein AH, Taylor WF, Jiang N-S (1977) Abnormalities of endogenous glucagon and insulin in unstable diabetes. Diabetes 26: 36–45

    Article  Google Scholar 

  61. Home PD, Gill GV, Husband DJ, Massi-Benedetti M, Marshall S, Alberti KGMM (1985) Hormonal and metabolic abnormaltities in brittle diabetes. In: Pickup JC (ed) Brittle diabetes. Blackwell, Oxford, pp 167–180

    Google Scholar 

  62. Taylor R, Husband DJ, Marshal SM, Tunbridge WMG, Alberti KGMM (1984) Adipocyte insulin binding and insulin sensitivity in “brittle” diabetes. Diabetologia 27: 441–446

    Article  CAS  PubMed  Google Scholar 

  63. Sandler G (1979) Costs of unnecessary tests. Br Med J 2: 21–24

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Schade DS, Eaton RP, Drumm DA, Duckworth WC (1985) A clinical algorhythm to determine the etiology of brittle diabetes. Diabetes Care 8: 5–11

    Article  CAS  PubMed  Google Scholar 

  65. Schade DS, Drumm DA, Duckworth WC, Eaton RP (1985) The etiology of incapacitating brittle diabetes. Diabetes Care 8: 12–20

    Article  CAS  PubMed  Google Scholar 

  66. Schade DS, Santiago JV, Skyler JS, Rizza RA (1983) Unstable diabetes and insulin resistance. In: Intensive insulin therapy. Excerpta Medica, Amsterdam, pp 264–283

    Google Scholar 

  67. Williams G, Pickup JC, Bowcock S, Cooke E, Keen H (1983) Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patients. Diabetologia 24: 91–94

    Article  CAS  PubMed  Google Scholar 

  68. Campbell IW, Kritz H, Najemnik C, Hagmueller G, Irsigler K (1984) Treatment of Type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device (“Infusaid”). Diabetes Res 1: 83–88

    CAS  PubMed  Google Scholar 

  69. Williams G, Pickup JC, Collins AGC, Keen H (1984) Prostaglandin E1 accelerates subcutaneous insulin absorption in insulin-dependent diabetics. Diabetic Med 1: 109–112

    Article  CAS  PubMed  Google Scholar 

  70. Pickup JC, Home PD, Bilous RW, Keen H, Alberti KGMM (1981) Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. Br Med J 282: 347–350

    Article  CAS  Google Scholar 

  71. Home PD, Massi-Benedetti M, Gill GV, Capaldo B, Shepherd GAA, Alberti KGMM (1982) Impaired subcutaneous absorption of insulin in “brittle” diabetes. Acta Endocrinol 101: 414–420

    CAS  PubMed  Google Scholar 

  72. Husband DJ, Marshal SM, Walford S, Hanning I, Wright PD, Alberti KGMM (1984) Continuous intraperitoneal insulin infusion in the management of severely brittle diabetes — a metabolic and clinical comparison with intravenous infusion. Diabetic Med 1: 99–104

    Article  CAS  PubMed  Google Scholar 

  73. Pozza G, Spotti D, Micossi P, Cristallo M, Melandri M, Piatti PM, Monti LD, Pontiroli AE (1983) Long-term continuous intraperitoneal insulin treatment in brittle diabetes. Br Med J 1: 255–256

    Article  Google Scholar 

  74. Baylis J (1981) Brittle diabetes: long term control with a portable continuous, intravenous insulin infusion system. Br Med J 283: 1207–1209

    Article  Google Scholar 

  75. Williams G, Pickup JC, Keen H (1985) Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications. Diabetes Care 8: 21–27

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, The Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, England

    G. V. Gill, S. Walford & K. G. M. M. Alberti

Authors
  1. G. V. Gill
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. S. Walford
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. K. G. M. M. Alberti
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gill, G.V., Walford, S. & Alberti, K.G.M.M. Brittle diabetes — present concepts. Diabetologia 28, 579–589 (1985). https://doi.org/10.1007/BF00281992

Download citation

  • Published: 01 August 1985

  • Issue Date: August 1985

  • DOI: https://doi.org/10.1007/BF00281992

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Insulin Infusion
  • Subcutaneous Insulin
  • Acanthosis Nigricans
  • Intercurrent Illness
  • Brittle Diabetes
Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Advertisement

Search

Navigation

  • Find a journal
  • Publish with us
  • Track your research

Discover content

  • Journals A-Z
  • Books A-Z

Publish with us

  • Journal finder
  • Publish your research
  • Open access publishing

Products and services

  • Our products
  • Librarians
  • Societies
  • Partners and advertisers

Our brands

  • Springer
  • Nature Portfolio
  • BMC
  • Palgrave Macmillan
  • Apress
  • Discover
  • Your US state privacy rights
  • Accessibility statement
  • Terms and conditions
  • Privacy policy
  • Help and support
  • Legal notice
  • Cancel contracts here

18.217.177.60

Not affiliated

Springer Nature

© 2025 Springer Nature